HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

(1S,2R)-(+)-Norephedrine

HCID 4786
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
14838-15-4
Standard SMILES
CC(N)C(O)c1ccccc1
InChIKey
DLNKOYKMWOXYQA-UHFFFAOYSA-N
Molecular formula
C9H13NO
Average molar mass
151.21 g/mol
Monoisotopic mass
151.09971404

Overview

Phenylpropanolamine is a sympathomimetic agent that acts as a nonselective adrenergic receptor agonist and norepinephrine reuptake inhibitor. It has been used as a decongestant and appetite suppressant. Currently, it is withdrawn from the market in Canada and the United States due to the risk for hemorrahgic strokes.

Names & identifiers

Preferred name
(1S,2R)-(+)-Norephedrine
IUPAC
2-amino-1-phenylpropan-1-ol
English name
Benzenemethanol, -alpha--(1-aminoethyl)-
Molecular formula
C9H13NO
Molecular weight
151.21

Names & synonyms

2-Amino-1-phenyl-1-propanol(1S,2R)-(+)-NorephedrineDTXSID70859305RefChem:393928DTXCID00196755628-077-148115-38-4alpha-(1-aminoethyl)benzyl alcoholNSC-120735UNII-683H0R96592-Amino-2-methyl-1-phenylethanol2-Amino-1-hydroxy-1-phenylpropane
Show more names
α-(1-Aminoethyl)benzenemethanolBenzenemethanol, α-(1-aminoethyl)-Benzenemethanol, -alpha--(1-aminoethyl)-
beta-Hydroxy-alpha-methylphenethylamineBenzenemethanol, alpha-(1-aminoethyl)-Benzenemethanol, .alpha.-(1-aminoethyl)-683H0R965937577-28-9Dexatrim(-)-Pseudo NorephedrineNorpseudoephedrine, (+)-

Database identifiers

CAS
14838-15-4、37577-28-9、48115-38-4
PubChem CID
4786
DTXSID
DTXSID70859305
ChEMBL
CHEMBL61006
EC Number
628-077-1
Nikkaji
J136.573H

Properties

Computed structural properties

XLogP
0.8
Topological polar surface area
46.3 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
2
Rotatable bonds
2
Heavy atoms
11
Formal charge
0
Complexity
110

Experimental & physicochemical properties

Drugs · 2 items

DEA NFLIS-Drug Category -> Phenethylamines (Amphetamines) (S)

Pharmaceuticals

SolubilityFreely soluble
Melting Point190-194 °C
Dissociation Constants9.44 (at 20 °C)

Physicochemical properties

Melting point
103 °C · 103 °C
Boiling point
122 °C · 122 °C(Press: 4-5 Torr)
Density
1.071 · 1.071±0.06 g/cm3(Predicted)
pka
12.07 · 12.07±0.45(Predicted)
FDA UNII
683 H0R9659 · 683H0R9659

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Chemistry & industry

Pharmacology

Pharmacodynamics · 1 item

Phenylpropanolamine (PPA), a sympathomimetic agent structurally similar to pseudoephedrine, is used to treat nasal congestion. Phenylpropanolamine is found in appetite suppressant formulations and with guaifenesinin in cough-cold formulations. In 2000, the FDA requested that all drug companies discontinue marketing products containing phenylpropanolamine, due to an increased risk of hemorrhagic stroke in women who used phenylpropanolamine.

Mechanism of Action · 1 item

Phenylpropanolamine acts directly on alpha- and, to a lesser degree, beta-adrenergic receptors in the mucosa of the respiratory tract. Stimulation of alpha-adrenergic receptors produces vasoconstriction, reduces tissue hyperemia, edema, and nasal congestion, and increases nasal airway patency. PPA indirectly stimulates beta-receptors, producing tachycardia and a positive inotropic effect.

Biological Half-Life2.1 to 3.4 hours.
Metabolism/MetabolitesHepatic
Absorption, Distribution and ExcretionReduced bioavailability (about 38%) from gastrointestinal tract because of first pass metabolism by monoamine oxidase in the stomach and liver.

Uses & manufacturing

UsesUse (kg; approx.) in Germany (2009): >100

Upstream & downstream products

Downstream products

CATHINONE

Related reactions

17 records
New reaction record
HRID 8741 reaction equation
HRID 8741As reactantuspto-grants-2006_08
HRID 27843 reaction equation
HRID 27843As productuspto-grants-1980_09
HRID 210630 reaction equation
HRID 210630As productTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
HRID 831320 reaction equation
HRID 831320As reactantTest data from https://doi.org/10.1039/C8SC04228D
HRID 969272 reaction equation
HRID 969272As reactantuspto-grants-2007_12
HRID 1117807 reaction equation
HRID 1117807As reactantTraining data from https://doi.org/10.1039/C8SC04228D (7/10)
HRID 1576841 reaction equation
HRID 1576841As reactantuspto-grants-1976_09
HRID 1593858 reaction equation
HRID 1593858As reactantuspto-grants-2007_11
Page 1 of 3

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes